Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day: Extramedullary disease (PFS was 24.2 months without EMD vs. 9.0 months with) but not paraskeletal disease portends inferior outcomes after CAR T cell therapy in myeloma; about half of relapses post-CAR T had EMD.”
Title: Extramedullary disease but not paraskeletal disease portends inferior outcomes after CAR T cell therapy in multiple myeloma
Authors: Darren Pan, Tarek H. Mouhieddine, Tianxiang Sheng, Weijia Fu, Erin Moshier, Joshua Richter, Samir Parekh, Sundar Jagannath, Adriana C. Rossi, Larysa J. Sanchez, Santiago Thibaud, Cesar Rodriguez, Hearn J. Cho and Shambavi Richard.
Read the Full Article on Bone Marrow Transplantation.
More posts featuring Robert Orlowski.
